糖尿病护理设备的全球市场 (2023-2030年):产品 (血糖监测系统设备)·各终端用户的规模·占有率·成长分析·预测

Global Diabetes Care Devices Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices), By End-use - Industry Forecast 2023-2030

出版日期: 2023年07月12日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球糖尿病护理设备的市场规模在2021年估算为267亿美元，从2022年的290亿2,000万美元，在预测期间中将以8.7％的年复合成长率推移，成长到2030年565亿7,000万美元的规模。

由于全球糖尿病患病率不断上升，全球糖尿病护理设备市场正在显着增长。这些设备有助于管理和监测血糖水平，改善患者的治疗结果。技术进步、糖尿病管理意识的提高以及老年人口的增长等因素人口正在推动市场增长。由于对糖尿病护理的微创和便携式设备的需求不断增长，预计未来几年市场将继续扩大。

本报告提供全球糖尿病护理设备的市场调查，彙整市场概要，市场的各种影响因素的分析，技术·革新趋势，法律制度，市场规模的转变·预测，各种区分·各地区的明细，竞争情形，主要企业简介等资讯。

摘要整理
调查手法
母市场分析
市场概要
市场规模
市场动态
- 促进因素
- 机会
- 阻碍因素
- 课题
主要市场洞察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- IP分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 革新矩阵
- 开发中产品的分析
- 宏观经济指标
- 主要投资分析
- 主要成功因素
- 竞争的程度
市场动态·预测
- 市场动态
  - 促进因素
  - 机会
  - 阻碍因素
  - 课题
法规情形
波特分析
Skyquest对未来阻碍的特别见解
全球糖尿病护理设备市场:各产品
- 市场概要
- 血糖监测系统设备
  - 自我血糖监测系统设备
  - 持续血糖监测仪
  - 试验带
  - 采血针
- 胰岛素通知设备
  - 胰岛素帮浦
  - 管附着帮浦
  - 无内胎泵
  - 笔 (可重复使用·抛弃式)
  - 笔型针头 (标准·安全性)
  - 注射器
  - 其他
全球糖尿病护理设备市场:各终端用户
- 市场概要
- 医院
- 门诊病人手术中心
- 诊断中心
- 居家照护
- 诊所
- 其他
全球糖尿病护理设备市场:各地区
- 市场概要
- 北美
- 欧洲
- 亚太地区
- 南美
- 中东·非洲
竞争情形
- 前五名公司的比较
- 主要企业的市场上的地位
- 主要企业的招聘策略
- 主要成功策略
- 市场上最近的活动
- 主要企业的市场占有率
- 主要企业简介
  - Abbott Laboratories
  - Ascensia Diabetes Care
  - Becton, Dickinson and Company
  - Dexcom, Inc.
  - Eli Lilly and Company
  - F. Hoffmann-La Roche AG
  - Insulet Corporation
  - Johnson & Johnson
  - Medtronic plc
  - Nova Biomedical
  - Novo Nordisk A/S
  - Omron Healthcare, Inc.
  - Sanofi S.A.
  - Tandem Diabetes Care, Inc.
  - Terumo Corporation
  - Trividia Health, Inc.
  - Ypsomed AG
  - ARKRAY Inc.
  - Glooko, Inc.
  - GlySens Incorporated

简介目录

Product Code: SQSG35B2039

Diabetes Care Devices Market size was valued at USD 26.7 billion in 2021 and is poised to grow from USD 29.02 billion in 2022 to USD 56.57 billion by 2030, growing at a CAGR of 8.7% in the forecast period (2023-2030).

The global diabetes care devices market is witnessing significant growth due to the rising prevalence of diabetes worldwide. These devices help in managing and monitoring blood glucose levels, improving patient outcomes. Factors such as technological advancements, increasing awareness about diabetes management, and the growing geriatric population are driving market growth. The market is expected to continue expanding in the coming years, driven by the increasing demand for minimally invasive and portable devices for diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of Diabetes Care Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Diabetes Care Devices Market is segmented on the basis of product type, end user, and region. By product, the Diabetes Care Devices Market segment is divided into blood glucose monitoring devices and insulin delivery devices. Blood glucose segment is further segmented into self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Insulin delivery devices are further segmented into insulin pumps (tubed pumps and tubeless pumps), pens (reusable and disposable), pen needles (standard and safety), syringes, and others. By end use, the market is segmented into hospitals, ambulatory surgery centers, diagnostic centers, home care, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The market is experiencing growth due to the increasing use of insulin-delivery devices and the growing prevalence of diabetes. Sedentary lifestyles and unhealthy choices have resulted in a rising number of Type-2 diabetes diagnoses. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, which can lead to the development of various chronic diseases. Consequently, there is a significant need to effectively manage and control diabetes.

Restrain

the global diabetes care devices market may encounter obstacles during the forecast period. Limited access to these devices in underdeveloped regions and challenges related to registration processes and reimbursement issues are expected to restrict market growth.

Trend

The growth of the diabetes monitoring devices segment is primarily driven by the increased adoption of test strips, self-monitoring blood glucose meters, and the growing demand for continuous glucose monitoring. Developing countries are witnessing a rise in awareness about the disease, contributing to this trend. The World Health Organization (WHO) reports that over 60% of the global population lacks sufficient physical activity. Active employment is considered vital for maintaining a healthy lifestyle, and the risk of developing type 2 diabetes increases with higher body weight across all age groups. As individuals become more health-conscious, the global market offers lucrative growth opportunities for industry players.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Diabetes Care Devices Market by Product
- Market Overview
- Blood glucose monitoring devices (Self-monitoring blood glucose meters
- continuous glucose monitors
- testing strips
- lancets)
- Insulin Delivery Devices (Insulin delivery devices {insulin pumps-tubed pumps
- tubeless pumps}
- pens{reusable
- disposable}
- pen needles {standard
- safety}
- syringes
- others)
Global Diabetes Care Devices Market by End-use
- Market Overview
- Hospitals
- ambulatory surgery centres
- diagnostic centres
- home care
- clinics
- others
Global Diabetes Care Devices Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott Laboratories
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ascensia Diabetes Care
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Becton, Dickinson and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Dexcom, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffmann-La Roche AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Insulet Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson & Johnson
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Nova Biomedical
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novo Nordisk A/S
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Omron Healthcare, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Tandem Diabetes Care, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Terumo Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Trividia Health, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ypsomed AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- ARKRAY Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Glooko, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlySens Incorporated
Company Overview
Business Segment Overview
Financial Updates
Key Developments